Latest News  

FDA Approves Ustekinumab for Crohn’s Disease

(Reuters)—Johnson & Johnson says on Monday that the U.S. Food and Drug Administration approved the company’s psoriasis drug, ustekinumab (Stelara), for use in adults with… [Read More]

Why Rheumatologists Should Care about Zika: How It’s Transmitted & Spreading in the U.S.

Rheumatologists are already familiar with one mosquito-borne virus, chikungunya, whose presentation mimics arthritis. Now, with its recent spread to Puerto Rico and the Southeastern U.S., Zika, another mosquito-borne virus, has become an international public health concern. Sexual transmission of the virus was recently confirmed, expanding the virus’s threat… [Read More]

FDA Approves Adalimumab-atto, a Biosimilar of Humira

WASHINGTON (Reuters)—The U.S. Food and Drug Administration on Friday approved a cheaper, biosimilar version of AbbVie’s top-selling arthritis drug, adalimumab (Humira). The drug, adalimumab-atto (Amjevita),… [Read More]

How to Thrive—Not Just Survive—as a New Manager, Part 1

The transition from employee to manager in a rheumatology practice can be daunting. But according to experts, setting clear roles and responsibilities and cultivating professional relationships with your employees ultimately help make you and the practice successful… [Read More]

Celltrion Accelerates U.S. Launch of Infliximab-dyyb, a Remicade Biosimilar

After winning the initial patent infringement lawsuit filed by Janssen, Celltrion Inc. is now shipping Inflectra (infliximab-dyyb), a biosimilar of Remicade (infliximab), to the U.S… [Read More]

Is Arthroscopic Meniscal Surgery Effective?

A recent review examined the effectiveness of arthroscopic mensical surgery in treating meniscal injuries. Researchers determined that little evidence exists to support the use of arthroscopic meniscal surgery and more studies that directly compare it with nonoperative treatments are needed… [Read More]

View More Latest News »